Clinical trial

Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

NCT00395655

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2005-06-01

PhasePHASE2

Study timeline

Study start (unknown)2005-06-01Date precision: month

Registry last updated2006-11-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Locally Advanced Breast Cancerunresolved

Interventions

Hydralazine and magnesium valproate administrationDRUG

Core-needle biopsy of the breastPROCEDURE

Sponsors & collaborators

National Institute of Cancerologíalead sponsor

National Council of Science and Technology, Mexicocollaborator

Psicofarma, S.A. De C.V.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00395655 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.